Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Today, we announce progress in our Fabry disease program, achieving important derisking milestones in our pathway to anticipated BLA submission. Learn more:

16,994 görüntüleme • 1 yıl önce •via X (Twitter)

6 Yorum

Dan profil fotoğrafı
Dan1 yıl önce

Where’s the partnership that you’ve been referencing for the past 10 months?

GothamGirl profil fotoğrafı
GothamGirl1 yıl önce

@sandymacrae23 @johnmarkels @Franca_ole Sangamo moved the goal post AGAIN - in Feb 6th PR you noted potential BLA submission 2nd 1/2 2025, now you note Q1 2026. 3-6 month delay means more dilution for current shareholders without a partnership or sale of Fabry asset near-term.

Jasper profil fotoğrafı
Jasper1 yıl önce

Lol what an achievement So proud of you guys 😂😂

NextChapter profil fotoğrafı
NextChapter1 yıl önce

Nobody cares. You’re going to the out of business since the bonehead CEO doesn’t know anything other than diluting shareholders and giving out false dates

똠양꿈 profil fotoğrafı
똠양꿈1 yıl önce

Dillutuion again??

Trade Hatch profil fotoğrafı
Trade Hatch1 yıl önce

How do you spell bankruptcy? SANDYMACRAE! How this clown has been allowed to destroy this company and eviscerate its shareholders and employees is beyond me. Hands down the worst CEO of any biotech I have ever followed!

Benzer Videolar